251 related articles for article (PubMed ID: 25701633)
1. Diverse binding modes, same goal: The receptor recognition mechanism of botulinum neurotoxin.
Lam KH; Yao G; Jin R
Prog Biophys Mol Biol; 2015 Mar; 117(2-3):225-231. PubMed ID: 25701633
[TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
Jin R; Rummel A; Binz T; Brunger AT
Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
[TBL] [Abstract][Full Text] [Related]
3. The long journey of botulinum neurotoxins into the synapse.
Rummel A
Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
[TBL] [Abstract][Full Text] [Related]
4. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
[TBL] [Abstract][Full Text] [Related]
5. Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity.
Rummel A
Curr Top Microbiol Immunol; 2013; 364():61-90. PubMed ID: 23239349
[TBL] [Abstract][Full Text] [Related]
6. Neuronal selectivity of botulinum neurotoxins.
Poulain B; Lemichez E; Popoff MR
Toxicon; 2020 Apr; 178():20-32. PubMed ID: 32094099
[TBL] [Abstract][Full Text] [Related]
7. Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.
Fu Z; Chen C; Barbieri JT; Kim JJ; Baldwin MR
Biochemistry; 2009 Jun; 48(24):5631-41. PubMed ID: 19476346
[TBL] [Abstract][Full Text] [Related]
8. High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.
Lee K; Lam KH; Kruel AM; Perry K; Rummel A; Jin R
Biochem Biophys Res Commun; 2014 Apr; 446(2):568-73. PubMed ID: 24631690
[TBL] [Abstract][Full Text] [Related]
9. Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.
Strotmeier J; Mahrhold S; Krez N; Janzen C; Lou J; Marks JD; Binz T; Rummel A
FEBS Lett; 2014 Apr; 588(7):1087-93. PubMed ID: 24583011
[TBL] [Abstract][Full Text] [Related]
10. A Comprehensive Structural Analysis of
Gregory KS; Acharya KR
Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828407
[TBL] [Abstract][Full Text] [Related]
11. Association of botulinum neurotoxins with synaptic vesicle protein complexes.
Baldwin MR; Barbieri JT
Toxicon; 2009 Oct; 54(5):570-4. PubMed ID: 19362106
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin G binds synaptotagmin-II in a mode similar to that of serotype B: tyrosine 1186 and lysine 1191 cause its lower affinity.
Willjes G; Mahrhold S; Strotmeier J; Eichner T; Rummel A; Binz T
Biochemistry; 2013 Jun; 52(22):3930-8. PubMed ID: 23647335
[TBL] [Abstract][Full Text] [Related]
13. Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.
Davies JR; Liu SM; Acharya KR
Toxins (Basel); 2018 Oct; 10(10):. PubMed ID: 30347838
[TBL] [Abstract][Full Text] [Related]
14. Structural Analysis of Botulinum Neurotoxins Type B and E by Cryo-EM.
Košenina S; Martínez-Carranza M; Davies JR; Masuyer G; Stenmark P
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050991
[TBL] [Abstract][Full Text] [Related]
15. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of cell surface receptor recognition by botulinum neurotoxin B.
Chai Q; Arndt JW; Dong M; Tepp WH; Johnson EA; Chapman ER; Stevens RC
Nature; 2006 Dec; 444(7122):1096-100. PubMed ID: 17167418
[TBL] [Abstract][Full Text] [Related]
17. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
[TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor.
Rummel A; Häfner K; Mahrhold S; Darashchonak N; Holt M; Jahn R; Beermann S; Karnath T; Bigalke H; Binz T
J Neurochem; 2009 Sep; 110(6):1942-54. PubMed ID: 19650874
[TBL] [Abstract][Full Text] [Related]
19. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites.
Strotmeier J; Gu S; Jutzi S; Mahrhold S; Zhou J; Pich A; Eichner T; Bigalke H; Rummel A; Jin R; Binz T
Mol Microbiol; 2011 Jul; 81(1):143-56. PubMed ID: 21542861
[TBL] [Abstract][Full Text] [Related]
20. Unique ganglioside binding by botulinum neurotoxins C and D-SA.
Kroken AR; Karalewitz AP; Fu Z; Baldwin MR; Kim JJ; Barbieri JT
FEBS J; 2011 Dec; 278(23):4486-96. PubMed ID: 21554541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]